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Background: Diversity of cystic fibrosis (CF) phenotype in patients with the same CFTR-mutation raised the hypothesis that other factors
modulate the phenotype including “alternative” calcium-activated anion currents (CaCC). This study compares the mRNA expression levels of
candidate CaCC mediators in CF mouse models with wild type controls.
Methods: mBEST1, mBEST2, mCLC-3B, mCLC-4, mTTYH3, mTMEM16A, mTMEM16F, mTMEM16K, mCLCA1 to -6 and SLC26A9
mRNA were quantified in CF-relevant tissues in cftrtm1Cam and cftrTgH(neoim)Hgu mice and controls using real-time RT-qPCR.
Results: No consistent differences were observed except for mTTYH3 which was significantly down-regulated throughout the intestinal tract of
cftrtm1Cam mice.
Conclusions: Down-regulation of mTTYH3 may point towards its involvement in the complex CF pathology. However, the markedly reduced
expression argues against a direct compensatory action as an alternative anion conductance. If any of the other candidates plays a role as
modulator, factors other than transcriptional regulation and mRNA stability may be involved.
© 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Bestrophin; CLC; CLCA; Cystic fibrosis; mTTYH3; TMEM161. Introduction
Severity and clinical picture of CF is highly heterogeneous
despite the same CFTR-mutation even in CF siblings sharing
same environmental factors [1]. Interestingly, monozygous
twins are more similar in clinical phenotype and basic defect
than dizygous twins [2]. Therefore, genes other than CFTR have
been proposed to modulate the CF phenotype, many of them
affecting the general inflammatory and immune response [3].
A non-CFTR, 4,4′-diiso-thiocyanostilbene-2,2′-disulfonic acid
(DIDS)-sensitive, calcium-activated chloride conductance (CaCC)
has been described in murine cftr−/− tissues that may at least in
part compensate for deficiencies associated with defective CFTR
[4–6]. None of the candidate CaCC mediators, including bestro-
phins, tweety, CLC, TMEM16A, -F or -K, CLCA and SLC26A9⁎ Corresponding author. Tel.: +49 30 83862440; fax: +49 30 83862522.
E-mail address: gruber.achim@vetmed.fu-berlin.de (A.D. Gruber).
1569-1993/$ - see front matter © 2010 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2010.06.003[4,7–11], have, however, unequivocally been linked to the electro-
physiological profile measured in CF patients and mouse models.
Bestrophins form Ca2+-activated chloride channels in heter-
ologous expression systems. BEST1 and BEST2 are expressed in
the lungs, colon, liver and kidney and may play a role particularly
in Cl− secretion in mouse airways [8]. CLC proteins are grouped
into voltage-gated anion channels and Cl−–H+-exchangers
(Reviewed in [12]). Both are broadly expressed. The latter
group includes CLC-3B which co-localizes with CFTR-interact-
ing PDZ proteins in the Golgi [13] and CLC-4 which may play an
important role in the anion conductance across the brush border
membranes of enterocytes [9].Moreover, the clc-4 gene is located
on human chromosome 19q13, a region containing putative
modifier genes for CF [14]. The tweety family member TTYH3
accounts for large conductance, Ca2+-activated chloride currents
and is expressed in many excitable tissues [10,15]. mTMEM16A
has recently been discovered as a Ca2+-activated chloride channel
or subunit thereof based on electrophysiological analyses
suggesting characteristics of anion channels [7,16,17].d by Elsevier B.V. All rights reserved.
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colon, pancreas, liver, kidneys and stomach [7]. In murine
airways TMEM16A appears to be the dominant chloride
channel rather than CFTR [18]. TMEM16F and TMEM16K
could also contribute to this UTP activated CaCC current [18].
TMEM16F and TMEM16K are of special interest in the
respiratory tract where they have been shown to be expressed in
tracheal epithelium and mesenchyme [18]. Thus, all three
TMEM16 family members may potentially compensate for
defective CFTR function in the airways [18].
CLCA gene family members have been linked to DIDS-
sensitive chloride secretion in the human intestinal tract [4]. A
strong correlation was found between allelic variants at the
human hCLCA1 gene locus or, less likely, hCLCA4 and CFTR-
independent chloride conductance in rectal mucosa biopsies of
CF patients [4]. However, recent studies have revealed that
CLCA proteins may not represent channel proteins on their own
but may regulate other, yet unknown channels [19]. Like CFTR
the majority of CLCA proteins are predominantly expressed in
various secretory epithelial cells [20].
SLC26A9 is a chloride channel which significantly con-
tributes to anion secretion in airway epithelia [21]. Unlike
CaCC, SLC26A9 currents are inhibited by calcium [11].
However, its association with CFTR and transepithelial chloride
channel activity could make it an interesting target as alternative
chloride channel [11].
Based on the hypothesis that the proposed candidates with
compensatory roles for anion conductance in CF are up-regulated
on the transcriptional level in CF versus normal tissues [5,6] we
quantified their mRNA copy numbers in CF affected tissues
including lungs, gastro-intestinal tract, pancreas, liver and kidney
to help identify a molecule or regulatory pathway involved. The
candidate murine orthologs tested were mBEST1, mBEST2,
mCLC-3B mCLC-4, mTTYH3, TMEM16A, TMEM16F,
TMEM16K, mCLCA1 to -6 and SLC26A9. Two CF genotypes
inbred on two different genetic mouse backgrounds [22,23] were
employed to account for different functional defects and variable
other genetic influences.
2. Materials and Methods
2.1. Animals and tissue processing
Two CF mouse models and their wild type controls were
used, cftrtm1Cam on NMRI background and cftrTgH(neoim)Hgu on
BALB/c background. Animals were kept in individually
ventilated cages under specific pathogen free conditions
according to the guidelines of the Federation of European
Laboratory Animal Science Associations (FELASA). From the
third week of age, all wild type and cftrtm1Cam NMRI mice
received drinking water supplemented with 50 vol.% poly-
ethyleneglycol as an oral laxative (Oralav®; Braun, Melsungen,
Germany). Each group included five female 10-week-old mice
sacrificed by cervical dislocation. Following tissue samples
were snap-frozen in liquid nitrogen and stored at −80 °C:
stomach, duodenum, jejunum, caecum, colon, pancreas, liver,
lungs and kidneys.2.2. RNA isolation and reverse transcription
Total RNA was extracted from whole tissue samples using
Trizol (Invitrogen, Karlsruhe, Germany) and purified using the
RNeasy Mini Kit (Qiagen, Hilden, Germany) including digestion
with RNase-free DNase I (Qiagen). RNA templates were quality
checked and quantified using the NanoDrop® ND-1000 Spectro-
photometer (Peqlab, Wilmington, USA). Total RNA concentra-
tion ranged between approximately 1000 and 3000 ng/μl. The cut
off ratio of absorbance at 260 and 280 nm to assess the purity of
RNA sampleswas chosenN1.8. Approximately 500 ng total RNA
was reverse transcribed in 21 μl reaction volume using random
hexamer primers in the presence of RNase Out (SuperScript III;
Invitrogen). Alternatively, for quantification of mCLCA1, -2, -3,
-4, and -6, approximately 500 ng total RNA was reverse
transcribed (Omniscript; Qiagen) in 20 μl reaction volume for
1 h at 37 C using random hexamer primers in the presence of 100
units of recombinant ribonuclease inhibitor (Invitrogen).2.3. Real-time quantitative polymerase chain reaction
Primers and probes were designed using the Beacon
Designer 3.0 software (Premier Biosoft International, Palo
Alto, CA, USA). All primer pairs encompassed an intron to
exclude amplification of contaminating genomic DNA. Primer
and probe sequences for mCLCA1, mCLCA2 [24], mCLCA4
[25], mCLCA5 [26] mCLCA6 [27] and their specificities have
been reported previously. For mCLCA3 no cross-reactions were
detected when linearized cloned full cDNA samples of
mCLCA1, mCLCA2, mCLCA5 and mCLCA6, or PCR-derived
fragments of mCLCA4 were used as templates in a series of
dilutions containing 102 to 106 copies. Oligonucleotide
sequences and specifications are listed in Table 1.
In silico specificity screening of the primers and probes
was performed using NCBI nucleotide BLAST searches. All
nucleotide sequences had 100% identity only with the expected
cDNA sequence. Agarose gel electrophoresis and sequencing of
all PCR-products confirmed amplification of a single product of
expected size and sequence.
A fragment of the cDNA encoding murine elongation factor
1α (EF1a) was amplified in parallel as internal reference gene
[24,25,28].
RT-qPCR and data analyses were conducted using the
MX3000P Quantitative PCR System and MX Pro Software
(Stratagene, La Jolla, CA,USA). PCR-reactions were carried out in
96-well High Profile plates covered with optical-thin wall-caps for
real-time PCR (Kisker, Steinfurt, Germany). The plates contained
triplicates of each cDNA sample and duplicates of no-template and
positive controls. Gene of interest (GOI) and EF1a measurements
were run on the same plate to ensure equal amplification conditions.
The optimized reaction-mix contained 12.5 μl qPCR Mas-
terMix Plus Low ROX (Eurogentec, Seraing, Belgium),
300 nM of each primer, 200 nM probe, 1 μl cDNA, 5.0 mM
or 6.0 mM (mCLCA3, mCLCA5, mCLCA6, mTTYH3) MgCl2
and RNase-free water (Roth, Karlsruhe, Germany) to a final
volume of 25 μl. The thermal profile was 10 min at 95 °C
Table 1
Primer and probe sequences, amplicon length and annealing temperatures.
Gene
(reference)
GenBank
accession no.
Oligonucleotide Sequences (5′-3′) Amplicon
size, bp
Annealing
Temp., °C
mbest1 NM_011913 Primer (upstream) AGAGGAGAGGCTCCCATTGTG 89 60
Primer (downstream) CCCATCACCTGTGTCTGAACTG
TaqMan Probe FAM-CACCCAGCAGCCACCCTACTGAGCAG-TAMRA
mbest2 NM_145388 Primer (upstream) TCCAGGGCTCCACCTTTGATATAG 101 60
Primer (downstream) AAAGTCCCCGTGAACCTCTCC
TaqMan Probe FAM-CCATCCACGCCGTCCAGCCGCT-TAMRA
mclc-3b NM_173873.1 Primer (upstream) TGTGAGGTTGGGGCTGACTG 107 60
Primer (downstream) ACAATAACCACCAGAGACACAGTC
TaqMan Probe FAM-TCACACCACCTAAGCACGCAGCAGCC-TAMRA
mclc-4 NM_011334 Primer (upstream) AGATTCCCTCAGGTCTCTTCATCC 108 60
Primer (downstream) TGATCCAGTCATGGTGATGGTAGG
TaqMan Probe FAM-CTGCTCCACACCGATTCCCACCATCCG-TAMRA
mttyh3 NM_178642 Primer (upstream) GCCTGGTGCGTCATCATCAC 110 60
Primer (downstream) CGTAGTGAGTAGGTGGCTCGATG
TaqMan Probe FAM-CATCGCTGGTCTCGCCGTTGCCGTA-TAMRA
Second set of mttyh3 primers and probe for verification
mttyh3 NM_178642 Primer (upstream) GAACGGAAGTGAATCTCCAGCAC 104 60
Primer (downstream) CTCCACACCATCATAGCAGAAGC
TaqMan Probe FAM-CCGCCCTGGTGGACTGCCGCA-TAMRA
mtmem16a NM_178642 Primer (upstream) CACGCCCGAGTACATGGAAATG 84 60
Primer (downstream) GCGAAGAGTGGAGCCAGAGG
TaqMan Probe FAM-TCGGCTTTGTCACCCTGTTTGTTGCGT-TAMRA
mtmem16f NM_175344.3 Primer (upstream) ATGCAGATGATGACTAGGAAGGTC 92 60
Primer (downstream) TGGTCAAAGTTTTCCAGCACAATG
TaqMan Probe FAM-CCATCCTCATCGTCGTCCTCCTCCAGC-TAMRA
mtmem16k NM_133979.2 Primer (upstream) AGTCGCTGATGAGGAGACTGC 92 60
Primer (downstream) ACGTGTCCTCCAGCTTCTTCAG
TaqMan Probe FAM-CATCGTGACCCAAGTGTTCCCGCTGC-TAMRA
mclca1 NM_009899 Primer (upstream) GTGGACCAGCCTTTCTACATGTCTAG 114 65
[24] Primer (downstream) TGTGACACAGTTGCCTCTCTCA
TaqMan Probe FAM-ATCACTGGCACCAATGTGGTTCACAACT-TAMRA
mclca2 NM_030601 Primer (upstream) GGACCGGCCTTTCTACATTTCTAG 109 65
[24] Primer (downstream) CACACAGCTGCCTCTCTGACA
TaqMan Probe FAM-CACAGGCAAGAAGGTGGTCCACGA-TAMRA
mclca3 NM_017474 Primer (upstream) GAAATT CCCCAGCCCTGTAACAG 144 60
Primer (downstream) TCGGCACCTGCTCCGTTATC
TaqMan Probe FAM-CAAGCATTCGCCAAGGAGCCTCGCC-BHQ
mclca4 NM_139148 Primer (upstream) ACTAACCTAATAAGGATCATCAATGA 81 58
[25] Primer (downstream) AGTTCCGCCATTTGGGTATT
TaqMan Probe FAM-CTCCTACCTAGCGATCAGCACAAAGC-TAMRA
mclca5 NM_178697 Primer (upstream) ACGATGACCGGAAGCTGCTG 100 60
[26] Primer (downstream) ACCACCTCAAAGCCTTTCTTAACC
TaqMan Probe FAM-CCTGCCGACCGCCGTGTCCACT-TAMRA
mclca6 NM_207208 Primer (upstream) AATCAAGGCTGCAATTCAGGTAT 122 60
[27] Primer (downstream) TGTCTTTCACCTCATCAATACAGT
TaqMan Probe FAM-TGGCTGTGCTGTCCTCACCATCAC-TAMRA
slc26a9 NM_177243.4 Primer (upstream) AGTCATTGCCAAGACAGGTATGG 110 60
Primer (downstream) GGGACTTTCTCTGCTGTGTGG
TaqMan Probe FAM-ATCGCCGTCCTCTTCTCCTGCTTCCG-TAMRA
ef1a BC003969 Primer (upstream) CAAAAACGACCCACCAATGG 68 58, 60, 65
[28] Primer (downstream) GGCCTGGATGGTTCAGGATA
TaqMan Probe FAM-AGCAGCTGGCTTCACGCTCAGGTG-TAMRA
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annealing temperature listed in Table 1.
RT-qPCR protocols were established and optimized using
10-fold serial dilutions ranging from 102 to 106 copies of purified
mCLCA1 to -3 [25], mCLCA5 or mCLCA6 cloned in pcDNA3.1
[29] or purified (QIAquick; Qiagen) PCR-derived fragments
from cDNA templates from mouse colon for mCLCA4,EF1a, mBEST1, mBEST2, mCLC-3B, mCLC-4, mTTYH3,
mTMEM16A, mTMEM16F, mTMEM16K and mSLC26A9.
PCR efficiency was calculated based on the slope of the standard
curve plotted as log of starting template versus PCR cycle number.
Highly reproducible amplification efficiencies of between 95%and
105%were observed. The intra-assay standard deviation (SD) of 0
to 5% was consistent with a high reproducibility of the data [30].
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}Fig. 1. Comparison of relative expression levels between the wild type strains. For each organ analyzed – (A) stomach, duodenum, jejunum, caecum, colon, and
(B) pancreas, liver, lung and kidney – the relative mRNA copy numbers of the genes of interest (GOI) for both the BALB/c (black columns) and the NMRI (grey
columns) mice are plotted. Among the 15 candidate genes analyzed, mCLCA4 had strongest overall expression, followed by mCLC-3B, mTTYH3, mTMEM16A and
mCLCA3. mCLCA5, mBEST1 and mCLCA1 had lowest to negligible expression levels. In the box plots, outliers are marked by circles, extreme values by asterisks.
An outlier has a value of more than 1.5 quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a
hash marks a statistically significant difference between the BALB/c and NMRI wild type strain. The y-axis is scaled in log to the base of 10. n=5 mice per group.
355J. Braun et al. / Journal of Cystic Fibrosis 9 (2010) 351–3642.4. Quantification of target gene expression
The mean cycle threshold (Cq) value and corresponding SD
of the triplicates were given by the MX Pro Stratagene analysis
software. Cq value was based on the normalized baseline
corrected fluorescence (ΔRN). Relative mRNA copies were
calculated as ratios representing mRNA copy numbers of GOI
relative to EF1a (ratio=2Cq EF1a − Cq GOI =2ΔCq;[31].
2.5. Statistical analyses
Expressional differences were considered statistically signif-
icant for p≤0.05 in the Mann–Whitney-U-Test. The mean-value
of relative copies was interpreted as 0 if at least 4 out of 5 samplesper group had a difference of less than 5 Cq values between the
concentration unknown and the number of cycles run [30].
3. Results
3.1. Tissue expression pattern of candidate genes
All 15 candidate gene mRNAs were expressed in the gastro-
intestinal tract except for mCLCA6 and mBEST2 in the
stomach and SLC26A in the jejunum, caecum and colon.
All candidates except for mCLCA6 and mBEST2 were
expressed in the lung. Pancreas, liver and kidney had low
expression of mCLC-3B, mCLC-4, mTTYH3, mTMEM16A,
mTMEM16F, mTMEM16K, mCLCA1 and mCLCA2 (Fig. 1).
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}Fig. 2. Comparison of relative expression levels between the wild type and cftrTgH(neoim)Hgu mice on the BALB/c background. A) The relative mRNA copy numbers of
mBEST1, mBEST2, mCLC-3B, mCLC-4 and mTTYH3 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the BALB/c mice. B) The
relative mRNA copy numbers of mTMEM16A, mTMEM16F, mTMEM16K and SLC26A9 are plotted for both the wild type (black columns) and CF (grey columns)
tissues of the BALB/c mice. C) The relative mRNA copy numbers of the CLCA family members mCLCA1 to -6 are plotted for both the wild type (black columns) and
CF (grey columns) tissues of the BALB/c mice. In all the box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5
quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a hash marks a statistically significant
difference between the wild type and CF groups. The y-axis is scaled in log to the base of 10. n=5 mice per group.
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The relative copy numbers varied up to approximately 1000-
fold between the candidate genes within the expressing tissue
type. In the stomach SLC26A9, mCLC-3B, mTMEM16A and
mCLCA3 shared highest expression. mCLCA5 and mCLCA2
were expressed in low levels. In the intestinal tract, mCLCA4,
mCLC-3B, mCLCA3, mCLCA6, mTTYH3 and mTMEM16A
had strongest expression. In the lungs, mTTYH3, mTMEM16A
and mTMEM16F shared highest expression followed by
mCLC-4, mCLC-3B, SLC26A9 and mTMEM16K with
approximately 10-fold lower expression levels. Independent
of the expressing tissue, mCLCA5, mBEST1 and mCLCA1 had
overall lowest expression levels (Fig. 1).3.3. Comparison of expression levels between the two wild type
strains
Two candidates, mTMEM16A and mBEST1, each showed
significant differences in expression between the BALB/c and
NMRI wild type strains in the duodenum, jejunum, caecum
(only mTMEM16A) and colon (Fig. 1). mTMEM16A had up to
10-fold higher relative expression levels in these tissues of the
BALB/c strain. On the contrary, mBEST1 had up to 4-fold
higher relative expression levels in these tissues of the NMRI
strain. Significantly higher expression levels were noted in the
BALB/c strain compared to the NMRI strain for mCLC-3B in
the jejunum, 8-fold, and caecum, 16-fold, for mTMEM16F in
the colon, 5-fold, and for mTMEM16K in the stomach, 4-fold,
}Fig. 2 (continued ).
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significantly different expression levels between the two strains
in any of the tissues analyzed.
3.4. Comparison of expression levels between the CF and wild
type mice
The differences in expression levels are depicted in Fig. 2
(cftrTgH(neoim)Hgu) and Fig. 3 (cftrtm1Cam). The only candidate
with strong and consistent differential expression was mTTYH3
between the cftrtm1Cam model and the NMRI wild type mice
(Fig. 3a). Interestingly, this statistically significant down-
regulation was only observed in the small and large intestine
but not in the stomach, pancreas, liver, lungs or kidneys. The
fold-changes in mean expression values were −18-fold
(duodenum), −53-fold (jejunum), −1130-fold (caecum) and
−443-fold (colon). Of note, no down-regulation of mTTYH3
was observed in the cftrTgH(neoim)Hgu model which possesses a
milder disease phenotype [22,23].
All other candidate genes had only sporadically different
expression in select tissues (Figs. 2 and 3). Among these were
down-regulations of mCLCA1 in the stomach, mCLCA2 in the
kidney and mCLCA6 in the duodenum of the BALB/c strain, as
well as mCLC-4 in the caecum and mCLCA4 in the kidney of
the NMRI strain. None of the tissues of both CF models had up-
regulated expression of any of the genes tested.
Figs. 2 and 3 also highlight the tissue distribution patterns
of the individual mRNA species. mBEST1 was primarily
expressed in the lung, colon and kidney, mBEST2 in the
colon and mCLC-3B, mCLC-4, mTTYH3, mTMEM16A,
mTMEM16F and mTMEM16K in all tissues investigated.
SLC26A9 was expressed in the stomach and lungs. Of the
murine CLCA family members, mCLCA1 was expressed in all
tissues, mCLCA2 was primarily expressed in the intestinal tract,
mCLCA3 in the gastrointestinal tract, mCLCA4 in the intestinal
tract, mCLCA5 in the stomach and mCLCA6 was exclusively
detected in the intestinal tract.
3.5. Comparison of expression levels between the two CF
models
The only consistent and statistically significant difference
between the cftrTgH(neoim)Hgu and cftrtm1Cam models was again
observed for mTTYH3 throughout the small and large intestine.
Here, the cftrtm1Cam mice had markedly reduced mean ex-
pression levels when compared to the cftrTgH(neoim)Hgu mice
with fold-changes in mean expression levels of −8-fold
(duodenum), −5-fold (jejunum), −125-fold (caecum) and −46-
fold (colon). Importantly, this difference was neither observed
between the NMRI and BALB/c wild type mice nor between the
cftrTgH(neoim)Hgu mice and their wild type BALB/c controls.
Except for mBEST1 and mCLCA1 which were higher
expressed in the cftrtm1Cam mice in the stomach or duodenum,
respectively, and mTMEM16A which was more highly
expressed in the stomach of the cftrTgH(neoim)Hgu mice, no
further differences were observed between the two models.
However, this comparsion should be interpreted with cautionbecause the cftrTgH(neoim)Hgu model on the BALB/c background
is different to the cftrtm1Cam model on the NMRI background,
both in terms of level of genetic background and residual CFTR
function [22,23].
4. Discussion
Our data failed to provide evidence that any of the 15
candidate genes tested is up-regulated in CF-relevant tissues in
terms of overall mRNA copy number, either due to transcrip-
tional overexpression or increased mRNA stability. Tissues
investigated included lungs, gastro-intestinal tract, pancreas,
liver and kidneys. The hypothesis that CF mice fail to develop
significant airway or pancreas pathology due to compensatory
transcriptional up-regulation of an alternative chloride secretory
pathway can therefore be rejected for these candidates.
However, it cannot be excluded that any of the gene products
are regulated on post-transcriptional levels or by modulation of
the protein activation status. Of note, the mRNA tissue
distribution patterns in the wild type mice matched and
complemented results of previous studies [10,24–27,32].
To account for potentially different influences dependent on
the kind of CFTR-dysfunction, two separate CF mouse models
were used: cftrtm1Cam mice mimic the complete functional
CFTR-defect [23] while cftrTgH(neoim)Hgu mice display a milder
CF phenotype due to residual wild type CFTR expression [22].
The cftrTgH(neoim)Hgu mice even possess increased DIDS-
sensitive chloride secretion in their intestine compared to wild
type controls [33] implying that they may be useful to identify
the molecular basis for that current. However, we failed to
detect any transcriptional upregulation of alternative chloride
secretory pathways in this study and the molecular basis of this
current in cftrTgH(neoim)Hgu mice [33] remains elusive.
Interestingly, two candidate genes were differently expressed
between the two strains tested in all intestinal segments:
mTMEM16A mRNA copies were approximately 10-fold higher
in the BALB/c strain whereas mRNA copies of mBEST1 were
approximately 4-fold higher in the NMRI strain. The three
candidate genes mCLC-3B, mTMEM16F and mTMEM16K had
between 4- and 16-fold higher expression levels in gastro-
intestinal segments of the BLAB/c strain. Strain specific
differences in copy numbers have already been observed for
cftr [34] and for clca gene family members [25] and likely
represent random results of inbreeding. Whether the different
mRNA expression levels actually coincide with different protein
expression or function and any effects on the distinct pathologies
of the different CF mouse models used here [22,23] remain to be
established.
A second interesting result of this study is that the tweety
chloride channel mTTYH3 is markedly down-regulated
throughout the intestinal tract of the cftrtm1Cam mice but not
the cftrTgH(neoim)Hgu mice. We would have liked to corroborate
this finding on the protein level by confirming decreased protein
expression or reduced cellular distribution but antibodies for
immunohistochemical protein detection or immunoblotting
experiments are unavailable for mTTYH3. Therefore, we
performed an additional real time RT-qPCR assay using a
360 J. Braun et al. / Journal of Cystic Fibrosis 9 (2010) 351–364
}Fig. 3. Comparison of relative expression levels between the wild type and cftrtm1Cam mice on the NMRI background. A) The relative mRNA copy numbers of
mBEST1, mBEST2, mCLC-3B, mCLC-4 and mTTYH3 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the NMRI mice. B) The
relative mRNA copy numbers of mTMEM16A, mTMEM16F, mTMEM16K and SLC26A9 are plotted for both the wild type (black columns) and CF (grey columns)
tissues of the NMRI mice. C) The relative mRNA copy numbers of the CLCA family members mCLCA1 to -6 are plotted for both the wild type (black columns) and
CF (grey columns) tissues of the NMRI mice. In all the box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5
quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a hash marks a statistically significant
difference between the wild type and CF groups. The y-axis is scaled in log to the base of 10. n=5 mice per group.
361J. Braun et al. / Journal of Cystic Fibrosis 9 (2010) 351–364second set of primers and probe (Table 1) that amplify a
segment from a different region of the mTTYH3 open reading
frame. The results fully confirmed the down-regulation in the
intestine of cftrtm1Cam mice (data not shown). These observa-
tions suggest that mTTYH3 may be involved in the CF-
pathology and that the effect is only associated with the more
severe phenotype of the cftrtm1Cam model [23].
To date the electrophysiological behavior of mTTYH3 in CF
tissues and cell lines has not been systematically investigated,
nor has its potential interrelationship with CFTR. In CHO cell
lines it demonstrates characteristic behavior as seen in bona fide
maxi-Cl− channels and its electrophysiological properties made
it a candidate for the CaCC seen in several CF epithelial tissues
[10,15]. Our transcriptional analyses, however, imply thatmTTYH3 may be less strongly expressed in the worse intestinal
phenotype. CaCC are further implicated to be down-regulated
by CFTR and up-regulated in a defective CFTR environment
[35]. The opposite seems to be true for mTTYH3 in the latter
scenario. Reduced mTTYH3 expression in the cftrtm1Cam model
may be a direct or indirect consequence of deficient CFTR
function, without any possible explanation at this time. It could
even be possible that reduced mTTYH3 exacerbates disease
severity in the complete cftr knockout. A similar mechanism has
in fact been demonstrated for the ENaC Na+ channel. In mouse
lungs with absent CFTR, the inhibitory effect of CFTR on the
ENaC sodium channel is reduced, leading to impaired mucosal
membrane hydration and, ultimately, lung function [36]. Future
work will have to address any functional consequences of the
}Fig. 3 (continued ).
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CFTR-associated pathways.
The strongest candidate for a modifier role in the lungs,
mTMEM16A, had prominent expression in the lungs compared
to the other genes tested both in the wild type and the CF
models, however, without a significant difference between both
models. The data are well in line with speculations that
mTMEM16A is the predominant chloride channel in mouse
airways [18] but its expression seems independent of the
presence of CFTR.
One technical drawback of this study is the variability of
mRNA copy numbers for the same candidate genes between
individual mice belonging to the same group. We quantified the
degrees of variability using the statistically defined terms of
outliers and extreme values (Figs. 1 to 3). Repeated RT-qPCR
assays confirmed high reproducibility for each mRNA copy
number per individual mouse and tissue. Thus, the variability
measured in our experiments appear to reflect true interindivid-
ual differences in expression levels which have been observed
for many other genes in previous studies, including murine cftr
[34]. On the other hand, these variations may have concealed or
falsely conveyed detection of statistically significant differences
in some of our comparisons, including some of the significant
differences observed in low numbers randomly distributed
between the groups without a recognizable biological context.
Taken together, the results of our study indicate that none of
the candidate genes tested is transcriptionally up-regulated in
the two CF mouse models. Consistently reduced mRNA copy
numbers of mTTHY3 throughout the intestine of cftrtm1Cam
mice however suggest that the tweety large conductance
calcium-activated chloride channel may be involved in the
complex CF pathology. If any of the other candidates does play
a role as modulator, factors other than transcriptional regulation
and mRNA stability may be involved.
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